127 Startups
  • Sector
  • Participated in
  • Year of participation

D4 Diagnostics

  • 2022
  • Diagnostics
  • Venture Challenge
D4 Diagnostics has developed D4BST to quantify the number of immune cells in tumors prior to treatment. D4BST is an assay for accurate, fast and reliable quantification of B-, Switched B- and T cells in traces of DNA from tumors or its surrounding environment.

Digest Inn

  • 2016
  • Enabling Technology
  • Venture Challenge
Assisting people to make diet-related lifestyle changes through gaming

DualTpharma

  • 2012
  • Other
  • Therapeutics
A new class of dual drugs for cancer treatment which are well tolerated and can be taken orally

EdgeLeap

  • 2013
  • Enabling Technology
  • Venture Challenge
EdgeLeap is an information technology company pushing AI to its limits to surface business relevant insights from continuous stream of world’s information, helping their clients can make intelligent strategic decisions every day.

Encare Biotech

  • 2010
  • 2011
  • Other
  • Therapeutics
  • Venture Challenge
Firbornectin-EDA Monoclonal antibody for the prevention of chronic heart failure

Encytos

  • 2021
  • Enabling Technology
  • Venture Challenge
Encytos has developed a micro(nano)structured (topographic) inorganic substrate for spheroid and organoid cell growth.

Exbiome

  • 2015
  • Diagnostics
  • Venture Challenge
Simple blood tests to detect cancer

ExCulture

  • 2023
  • Therapeutics
  • Venture Challenge
Opposed to the current heparin production method, our technology has the potential to ensure supply security, reduce risk of contamination and remove dependency on animal material.

Exovectory

  • 2018
  • Enabling Technology
  • Therapeutics
  • Venture Challenge
Optimal delivery to ensure effective treatment of cancer and more

Fybrix

  • 2023
  • Enabling Technology
  • Venture Challenge
With Fybrix, we offer a synthetic, customizable and animal-free 3D cell culture material that uniquely mimics the native cell environment, in contrast to other synthetic materials that have been introduced in the market.